Janet Sawicki

TitleVolunteer Faculty
InstitutionThomas Jefferson University
DepartmentFaculty Records and Publicatio - Thomas Jefferson University
Address833 Chestnut Street
Philadelphia PA 19023
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Peng W, Furuuchi N, Aslanukova L, Huang YH, Brown SZ, Jiang W, Addya S, Vishwakarma V, Peters E, Brody JR, Dixon DA, Sawicki JA. Elevated HuR in Pancreas Promotes a Pancreatitis-Like Inflammatory Microenvironment That Facilitates Tumor Development. Mol Cell Biol. 2018 02 01; 38(3). PMID: 29133460.
      Citations:    
    2. Zugates GT, Peng W, Zumbuehl A, Jhunjhunwala S, Huang YH, Langer R, Sawicki JA, Anderson DG. Rapid Optimization of Gene Delivery by Parallel End-modification of Poly(?-amino ester)s. Mol Ther. 2007 Jul; 15(7):1306-1312. PMID: 28182918.
      Citations:    
    3. Huang YH, Peng W, Furuuchi N, DuHadaway JB, Jimbo M, Pirritano A, Dunton CJ, Daum GS, Leiby BE, Brody JR, Sawicki JA. Insights from HuR biology point to potential improvement for second-line ovarian cancer therapy. Oncotarget. 2016 Apr 19; 7(16):21812-24. PMID: 26943573.
      Citations:    
    4. Romeo C, Weber MC, Zarei M, DeCicco D, Chand SN, Lobo AD, Winter JM, Sawicki JA, Sachs JN, Meisner-Kober N, Yeo CJ, Vadigepalli R, Tykocinski ML, Brody JR. HuR Contributes to TRAIL Resistance by Restricting Death Receptor 4 Expression in Pancreatic Cancer Cells. Mol Cancer Res. 2016 07; 14(7):599-611. PMID: 27053682.
      Citations:    
    5. Huang YH, Peng W, Furuuchi N, Gerhart J, Rhodes K, Mukherjee N, Jimbo M, Gonye GE, Brody JR, Getts RC, Sawicki JA. Delivery of Therapeutics Targeting the mRNA-Binding Protein HuR Using 3DNA Nanocarriers Suppresses Ovarian Tumor Growth. Cancer Res. 2016 Mar 15; 76(6):1549-59. PMID: 26921342.
      Citations:    
    6. Jimbo M, Blanco FF, Huang YH, Telonis AG, Screnci BA, Cosma GL, Alexeev V, Gonye GE, Yeo CJ, Sawicki JA, Winter JM, Brody JR. Targeting the mRNA-binding protein HuR impairs malignant characteristics of pancreatic ductal adenocarcinoma cells. Oncotarget. 2015 Sep 29; 6(29):27312-31. PMID: 26314962.
      Citations:    
    7. Blanco FF, Jimbo M, Wulfkuhle J, Gallagher I, Deng J, Enyenihi L, Meisner-Kober N, Londin E, Rigoutsos I, Sawicki JA, Risbud MV, Witkiewicz AK, McCue PA, Jiang W, Rui H, Yeo CJ, Petricoin E, Winter JM, Brody JR. The mRNA-binding protein HuR promotes hypoxia-induced chemoresistance through posttranscriptional regulation of the proto-oncogene PIM1 in pancreatic cancer cells. Oncogene. 2016 05; 35(19):2529-41. PMID: 26387536.
      Citations:    
    8. Tholey RM, Lal S, Jimbo M, Burkhart RA, Blanco FF, Cozzitorto JA, Eisenberg JD, Jiang W, Iacobuzio-Donahue CA, Witkiewicz AK, Glbert M, Yeo CJ, Brody JR, Sawicki JA, Winter JM. MUC1 Promoter-Driven DTA as a Targeted Therapeutic Strategy against Pancreatic Cancer. Mol Cancer Res. 2015 Mar; 13(3):439-48. PMID: 25336517.
      Citations:    
    9. Lal S, Burkhart RA, Beeharry N, Bhattacharjee V, Londin ER, Cozzitorto JA, Romeo C, Jimbo M, Norris ZA, Yeo CJ, Sawicki JA, Winter JM, Rigoutsos I, Yen TJ, Brody JR. HuR posttranscriptionally regulates WEE1: implications for the DNA damage response in pancreatic cancer cells. Cancer Res. 2014 Feb 15; 74(4):1128-40. PMID: 24536047.
      Citations:    
    10. Burkhart RA, Peng Y, Norris ZA, Tholey RM, Talbott VA, Liang Q, Ai Y, Miller K, Lal S, Cozzitorto JA, Witkiewicz AK, Yeo CJ, Gehrmann M, Napper A, Winter JM, Sawicki JA, Zhuang Z, Brody JR. Mitoxantrone targets human ubiquitin-specific peptidase 11 (USP11) and is a potent inhibitor of pancreatic cancer cell survival. Mol Cancer Res. 2013 Aug; 11(8):901-11. PMID: 23696131.
      Citations:    
    11. Tholey R, Sawicki JA, Brody JR. Molecular-based and alternative therapies for pancreatic cancer: looking "out of the box". Cancer J. 2012 Nov-Dec; 18(6):665-73. PMID: 23187855.
      Citations:    
    12. Peng W, Dunton C, Holtz D, Parva M, Stampler K, Forwood M, Gogoi R, Lace MJ, Anderson DG, Sawicki JA. DNA nanotherapy for pre-neoplastic cervical lesions. Gynecol Oncol. 2013 Jan; 128(1):101-106. PMID: 23103931.
      Citations:    
    13. Lande L, Peterson DD, Gogoi R, Daum G, Stampler K, Kwait R, Yankowski C, Hauler K, Danley J, Sawicki K, Sawicki J. Association between pulmonary mycobacterium avium complex infection and lung cancer. J Thorac Oncol. 2012 Sep; 7(9):1345-51. PMID: 22699888.
      Citations:    
    14. Peng W, Bao Y, Sawicki JA. Epithelial cell-targeted transgene expression enables isolation of cyan fluorescent protein (CFP)-expressing prostate stem/progenitor cells. Transgenic Res. 2011 Oct; 20(5):1073-86. PMID: 21222155.
      Citations:    
    15. Huang YH, Cozzitorto JA, Richards NG, Eltoukhy AA, Yeo CJ, Langer R, Anderson DG, Brody JR, Sawicki JA. CanScript, an 18-Base pair DNA sequence, boosts tumor cell-specific promoter activity: implications for targeted gene therapy. Cancer Biol Ther. 2010 Nov 01; 10(9):878-84. PMID: 20798601.
      Citations:    
    16. Huang YH, Zugates GT, Peng W, Holtz D, Dunton C, Green JJ, Hossain N, Chernick MR, Padera RF, Langer R, Anderson DG, Sawicki JA. Nanoparticle-delivered suicide gene therapy effectively reduces ovarian tumor burden in mice. Cancer Res. 2009 Aug 01; 69(15):6184-91. PMID: 19643734.
      Citations:    
    17. Huang YH, Bao Y, Peng W, Goldberg M, Love K, Bumcrot DA, Cole G, Langer R, Anderson DG, Sawicki JA. Claudin-3 gene silencing with siRNA suppresses ovarian tumor growth and metastasis. Proc Natl Acad Sci U S A. 2009 Mar 03; 106(9):3426-30. PMID: 19208807.
      Citations:    
    18. Sawicki JA. Fetal microchimerism and cancer. Cancer Res. 2008 Dec 01; 68(23):9567-9. PMID: 19047129.
      Citations:    
    19. Showalter SL, Huang YH, Witkiewicz A, Costantino CL, Yeo CJ, Green JJ, Langer R, Anderson DG, Sawicki JA, Brody JR. Nanoparticulate delivery of diphtheria toxin DNA effectively kills Mesothelin expressing pancreatic cancer cells. Cancer Biol Ther. 2008 Oct; 7(10):1584-90. PMID: 19039293.
      Citations:    
    20. Colby JK, Klein RD, McArthur MJ, Conti CJ, Kiguchi K, Kawamoto T, Riggs PK, Pavone AI, Sawicki J, Fischer SM. Progressive metaplastic and dysplastic changes in mouse pancreas induced by cyclooxygenase-2 overexpression. Neoplasia. 2008 Aug; 10(8):782-96. PMID: 18670639.
      Citations:    
    21. Sawicki JA, Anderson DG, Langer R. Nanoparticle delivery of suicide DNA for epithelial ovarian cancer therapy. Adv Exp Med Biol. 2008; 622:209-19. PMID: 18546630.
      Citations:    
    22. Peng W, Anderson DG, Bao Y, Padera RF, Langer R, Sawicki JA. Nanoparticulate delivery of suicide DNA to murine prostate and prostate tumors. Prostate. 2007 Jun 01; 67(8):855-62. PMID: 17427200.
      Citations:    
    23. Zugates GT, Peng W, Zumbuehl A, Jhunjhunwala S, Huang YH, Langer R, Sawicki JA, Anderson DG. Rapid optimization of gene delivery by parallel end-modification of poly(beta-amino ester)s. Mol Ther. 2007 Jul; 15(7):1306-12. PMID: 17375071.
      Citations:    
    24. Peng W, Chen J, Huang YH, Sawicki JA. Tightly-regulated suicide gene expression kills PSA-expressing prostate tumor cells. Gene Ther. 2005 Nov; 12(21):1573-80. PMID: 16034457.
      Citations:    
    25. Bao Y, Peng W, Verbitsky A, Chen J, Wu L, Rauen KA, Sawicki JA. Human coxsackie adenovirus receptor (CAR) expression in transgenic mouse prostate tumors enhances adenoviral delivery of genes. Prostate. 2005 Sep 01; 64(4):401-7. PMID: 15761871.
      Citations:    
    26. Anderson DG, Peng W, Akinc A, Hossain N, Kohn A, Padera R, Langer R, Sawicki JA. A polymer library approach to suicide gene therapy for cancer. Proc Natl Acad Sci U S A. 2004 Nov 09; 101(45):16028-33. PMID: 15520369.
      Citations:    
    27. Morris RJ, Liu Y, Marles L, Yang Z, Trempus C, Li S, Lin JS, Sawicki JA, Cotsarelis G. Capturing and profiling adult hair follicle stem cells. Nat Biotechnol. 2004 Apr; 22(4):411-7. PMID: 15024388.
      Citations:    
    28. Peng W, Verbitsky A, Bao Y, Sawicki J. Regulated expression of diphtheria toxin in prostate cancer cells. Mol Ther. 2002 Oct; 6(4):537-45. PMID: 12377196.
      Citations:    
    29. Coleman CS, Pegg AE, Megosh LC, Guo Y, Sawicki JA, O'Brien TG. Targeted expression of spermidine/spermine N1-acetyltransferase increases susceptibility to chemically induced skin carcinogenesis. Carcinogenesis. 2002 Feb; 23(2):359-64. PMID: 11872645.
      Citations:    
    30. Sawicki JA, Rothman CJ. Evidence for stem cells in cultures of mouse prostate epithelial cells. Prostate. 2002 Jan 01; 50(1):46-53. PMID: 11757035.
      Citations:    
    31. Guo Y, Zhao J, Sawicki J, Peralta Soler A, O'Brien TG. Conversion of C57Bl/6 mice from a tumor promotion-resistant to a -sensitive phenotype by enhanced ornithine decarboxylase expression. Mol Carcinog. 1999 Sep; 26(1):32-6. PMID: 10487519.
      Citations:    
    32. Sawicki JA, Monks B, Morris RJ. Cell-specific ecdysone-inducible expression of FLP recombinase in mammalian cells. Biotechniques. 1998 Nov; 25(5):868-70, 872-5. PMID: 9821589.
      Citations:    
    33. Sawicki JA, Morris RJ, Monks B, Sakai K, Miyazaki J. A composite CMV-IE enhancer/beta-actin promoter is ubiquitously expressed in mouse cutaneous epithelium. Exp Cell Res. 1998 Oct 10; 244(1):367-9. PMID: 9770380.
      Citations:    
    34. Steel LF, Telly DL, Leonard J, Rice BA, Monks B, Sawicki JA. Elements in the murine c-mos messenger RNA 5'-untranslated region repress translation of downstream coding sequences. Cell Growth Differ. 1996 Oct; 7(10):1415-24. PMID: 8891345.
      Citations:    
    35. Megosh L, Gilmour SK, Rosson D, Soler AP, Blessing M, Sawicki JA, O'Brien TG. Increased frequency of spontaneous skin tumors in transgenic mice which overexpress ornithine decarboxylase. Cancer Res. 1995 Oct 01; 55(19):4205-9. PMID: 7671221.
      Citations:    
    36. Sawicki JA, Impellizeri A, O'Brien TG. Effects of exogenous putrescine on murine preimplantation development in vitro. Dev Biol. 1991 Dec; 148(2):620-4. PMID: 1743405.
      Citations:    
    Sawicki's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (234)
    Explore
    _
    Co-Authors (22)
    Explore
    _
    Similar People (60)
    Explore
    _
    Same Department Expand Description
    Explore
    _